{
     "PMID": "28664455",
     "OWN": "NLM",
     "STAT": "Publisher",
     "LR": "20170630",
     "IS": "1559-1182 (Electronic) 0893-7648 (Linking)",
     "DP": "2017 Jun 29",
     "TI": "Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.",
     "LID": "10.1007/s12035-017-0669-1 [doi]",
     "AB": "The activation of c-Jun-N-terminal kinases (JNK) pathway has been largely associated with the pathogenesis and the neuronal death that occur in neurodegenerative diseases. Altogether, this justifies why JNKs have become a focus of screens for new therapeutic strategies. The aim of the present study was to identify the role of the different JNK isoforms (JNK1, JNK2, and JNK3) in apoptosis and inflammation after induction of brain damage. To address this aim, we induced excitotoxicity in wild-type and JNK knockout mice (jnk1 (-/-) , jnk2 (-/-) , and jnk3 (-/-) ) via an intraperitoneal injection of kainic acid, an agonist of glutamic-kainate-receptors, that induce status epilepticus.Each group of animals was divided into two treatments: a single intraperitoneal dose of saline solution, used as a control, and a single intraperitoneal dose (30 mg/kg) of kainic acid. Our results reported a significant decrease in neuronal degeneration in the hippocampus of jnk1 (-/-) and jnk3 (-/-) mice after kainic acid treatment, together with reduced or unaltered expression of several apoptotic genes compared to WT treated mice. In addition, both jnk1 (-/-) and jnk3 (-/-) mice exhibited a reduction in glial reactivity, as shown by the lower expression of inflammatory genes and a reduction of JNK phosphorylation. In addition, in jnk3 (-/-) mice, the c-Jun phosphorylation was also diminished.Collectively, these findings provide compelling evidence that the absence of JNK1 or JNK3 isoforms confers neuroprotection against neuronal damage induced by KA and evidence, for the first time, the implication of JNK1 in excitotoxicity. Accordingly, JNK1 and/or JNK3 are promising targets for the prevention of cell death and inflammation during epileptogenesis.",
     "FAU": [
          "de Lemos, Luisa",
          "Junyent, Felix",
          "Camins, Antoni",
          "Castro-Torres, Ruben Dario",
          "Folch, Jaume",
          "Olloquequi, Jordi",
          "Beas-Zarate, Carlos",
          "Verdaguer, Ester",
          "Auladell, Carme"
     ],
     "AU": [
          "de Lemos L",
          "Junyent F",
          "Camins A",
          "Castro-Torres RD",
          "Folch J",
          "Olloquequi J",
          "Beas-Zarate C",
          "Verdaguer E",
          "Auladell C"
     ],
     "AD": "Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Universitat de Barcelona, Avda Diagonal 641, E-08028, Barcelona, Spain. Instituto Gulbenkian de Ciencia, Rua da Quinta Grande 6, 2780-156, Oeiras, Portugal. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Universitat de Barcelona, Avda Diagonal 641, E-08028, Barcelona, Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Universitat de Barcelona, Avda Diagonal 641, E-08028, Barcelona, Spain. Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. Neuroscience Institute, University of Barcelona, Barcelona, Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Universitat de Barcelona, Avda Diagonal 641, E-08028, Barcelona, Spain. Laboratorio de Regeneracion Neural, Departamento de Biologia Celular y Molecular, CUCBA, Universidad de Guadalajara, Guadalajara, Mexico. Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. Unitat de Bioquimica, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Tarragona, Spain. Facultad de Ciencias de la Salud, Instituto de Ciencias Biomedicas, Universidad Autonoma de Chile, Talca, Chile. Laboratorio de Regeneracion Neural, Departamento de Biologia Celular y Molecular, CUCBA, Universidad de Guadalajara, Guadalajara, Mexico. Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. Neuroscience Institute, University of Barcelona, Barcelona, Spain. Departament de Biologia Cel.lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain. Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. cauladell@ub.edu. Neuroscience Institute, University of Barcelona, Barcelona, Spain. cauladell@ub.edu. Departament de Biologia Cel.lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain. cauladell@ub.edu.",
     "AUID": [
          "ORCID: http://orcid.org/0000-0001-8345-1859"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170629",
     "PL": "United States",
     "TA": "Mol Neurobiol",
     "JT": "Molecular neurobiology",
     "JID": "8900963",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Excitotoxicity",
          "Hippocampus",
          "Inflammation",
          "Kainic acid",
          "Knockout mice",
          "Neurodegeneration",
          "Neuroprotection",
          "c-Jun N-terminal kinase"
     ],
     "EDAT": "2017/07/01 06:00",
     "MHDA": "2017/07/01 06:00",
     "CRDT": [
          "2017/07/01 06:00"
     ],
     "PHST": [
          "2017/04/07 00:00 [received]",
          "2017/06/20 00:00 [accepted]",
          "2017/07/01 06:00 [entrez]",
          "2017/07/01 06:00 [pubmed]",
          "2017/07/01 06:00 [medline]"
     ],
     "AID": [
          "10.1007/s12035-017-0669-1 [doi]",
          "10.1007/s12035-017-0669-1 [pii]"
     ],
     "PST": "aheadofprint",
     "SO": "Mol Neurobiol. 2017 Jun 29. pii: 10.1007/s12035-017-0669-1. doi: 10.1007/s12035-017-0669-1.",
     "term": "hippocampus"
}